Greater Cannabis Company (GCAN) Cash & Current Investments (2017 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Cash & Current Investments of $1439.0 in Q1 2026, up 76.56% quarter-over-quarter from $815.0 in Q4 2025, and down 96.89% on a YoY basis from $46213.0 in Q1 2025.
Greater Cannabis Company (GCAN) Cash & Current Investments (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Cash & Current Investments history runs 10 years deep, the most recent figure standing at $1439.0 for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 96.89% year-over-year to $1439.0; the TTM figure through Mar 2026 stood at $1439.0 (down 96.89% YoY), while the FY2025 annual figure was $815.0, down 98.58% from the prior year.
- Cash & Current Investments was $1439.0 for Q1 2026 at Greater Cannabis Company, up from $815.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $289094.0 in Q3 2022 to a low of $815.0 in Q4 2025.
- Historically, Cash & Current Investments has averaged $113720.4 across 5 years, with a median of $71299.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Cash & Current Investments slipped 28.47% in 2022, then tumbled 98.58% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $270030.0 in 2022, then plunged by 38.21% to $166859.0 in 2023, then tumbled by 65.62% to $57368.0 in 2024, then sank by 98.58% to $815.0 in 2025, then surged by 76.56% to $1439.0 in 2026.
- The last three Cash & Current Investments figures came in at $1439.0 (Q1 2026), $815.0 (Q4 2025), and $21355.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Greater Cannabis Company | - | - | - | 1,439.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,439.00 |
| Dec 31, 2025 | 815.00 |
| Sep 30, 2025 | 21,355.00 |
| Jun 30, 2025 | 26,712.00 |
| Mar 31, 2025 | 46,213.00 |
| Dec 31, 2024 | 57,368.00 |
| Sep 30, 2024 | 62,282.00 |
| Jun 30, 2024 | 80,316.00 |
| Mar 31, 2024 | 129,323.00 |
| Dec 31, 2023 | 166,859.00 |
| Sep 30, 2023 | 199,532.00 |
| Jun 30, 2023 | 240,747.00 |
| Dec 31, 2022 | 270,030.00 |
| Sep 30, 2022 | 289,094.00 |
| Dec 31, 2021 | 377,520.00 |
| Sep 30, 2021 | 456,358.00 |
| Jun 30, 2021 | 528,930.00 |
| Mar 31, 2021 | 316,722.00 |
| Dec 31, 2020 | 112,953.00 |
| Sep 30, 2020 | 178,632.00 |